h2o Therapeutics

News

AmerisourceBergen adds Parkinson’s app to DTx platform

h2o Therapeutics will soon be able to call on the marketing reach of pharma distributor AmerisourceBergen for its app for patients with Parkinson’s disease.

News

Akeso's ivonescimab extends survival in PD-L1+ lung cancer

Akeso's PD-1xVEGF drug ivonescimab improves survival in another late-stage Chinese trial, ahead of a key international study readout later this year.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Digital

Discover a new era of healthcare panel engagement: Grounded ...

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.

Editor's Picks